BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, a bioelectronic medicine company developing wearable therapies for chronic disease, announces two validating pieces of news for the non-invasive ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...

Renee Ryan is leaving the venture capital world behind to take the reins at Cala Health, a promising California startup that has developed a wearable for treating essential tremor among other ...

Cala Health recently published a post-market surveillance study that demonstrates the long-term efficacy of its wrist-based wearable for people with essential tremor, finding that the device reduced ...

Please provide your email address to receive an email when new articles are posted on . Cala Trio, a wrist-worn device that stimulates wrist nerves to disrupt tremulous activity in the brain, safely ...

"Cala Health has emerged a pioneer in treating ET for the upper limbs through peripheral nerve stimulation. The Cala Trio™ delivers precise electrical pulses to the median and radial nerves in the ...

Benefit category designation and payment determination expands patient access to the only FDA-cleared non-invasive targeted therapy for hand tremor SAN MATEO, Calif.--(BUSINESS WIRE)--Cala, the ...

- Data presented at the Virtual ISPOR Europe 2020 conference underscore the growing need for ET treatment and support Cala Trio as a safe and effective ET therapy in real-world settings - Essential ...

In August, Cala Health Inc. reported results from its pivotal PROSPECT study showing significant improvement in hand tremors with use of its Cala Trio wearable neuromodulation therapy. Now the company ...